In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.

The in vitro susceptibilities of 12 strains of Chlamydia pneumonia to a new quinolone, OPC-17116; ofloxacin; and sparfloxacin were determined. OPC-17116 was slightly less active than sparfloxacin but more active than ofloxacin, with a MIC for 90% of strains tested and a minimal chlamydiacidal concen...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	Antimicrob Agents Chemother
Principais autores:	Roblin, P M, Montalban, G, Hammerschlag, M R
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology (ASM) 1994
נושאים:	Research Article
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188218/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8092845/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.6.1402
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!